StockData
NovoCure Ltd logo

NovoCure Ltd (NVCR) stock

NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3031% below fair value
$10.73−0.41 (-3.68%)

Close on Nov 18, 2026Market cap $1.25BP/E –Yield –

NovoCure market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

NovoCure's market cap was $1.40B on Nov 11, 2026, against $1.43B a year earlier. Over the last 5 years it ranged from $1.23B to $9.57B, with a median of $2.06B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.40B-3.6%
2025Dec 31, 2025$1.45B-55.1%
2024Dec 31, 2024$3.22B+102.1%
2023Dec 29, 2023$1.59B-79.3%
2022Dec 30, 2022$7.70B-1.2%
2021Dec 31, 2021$7.79B-55.7%
2020Dec 31, 2020$17.60B+111.1%
2019Dec 31, 2019$8.34B+167.8%
2018Dec 31, 2018$3.11B+72.5%
2017Dec 29, 2017$1.80B+168.1%
2016Dec 30, 2016$673.34M+142.2%
2015Dec 31, 2015$277.99M–

More NovoCure figures

See a number that looks wrong?